MedPath

Train-of-four Monitoring Using the Tetragraph

Not Applicable
Completed
Conditions
Surgery
Interventions
Device: Tetragraph (TM) NMT Monitor
Registration Number
NCT04475250
Lead Sponsor
Joseph D. Tobias
Brief Summary

This is a prospective study that will evaluate the feasibility of using the Tetragraph Neuromuscular Transmission Monitor in comparison to standard (visual) train-of-four assessment with a peripheral nerve stimulator in pediatric patients undergoing surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Pediatric patients requiring anesthetic care and use of neuromuscular blockade
  • Weight range of 20 - 60 kg
Exclusion Criteria
  • Patients with history of a peripheral neurologic or neuropathic disorder
  • Patients in whom the upper extremity cannot be used for TOF monitoring
  • Patients undergoing a surgical procedure in which neuromuscular blockade is not required
  • Edematous patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TetragraphTetragraph (TM) NMT Monitor-
Primary Outcome Measures
NameTimeMethod
Recovered TOFr (%)At the end of surgery (maximum 7 hours from baseline)

Train of four (TOF) is measured by giving 4 quick electrical pulses to the muscle and counting the number of muscle twitches. Recovered TOFr is the ratio between the fourth twitch of the train of four (TOF) sequence (T4) and the first (T1) after recovery from the neuromuscular blocking agent and then multiplied by 100 to get a percentage. A TOFr greater than or equal to 90% indicates adequate recovery from the neuromuscular block.

Baseline TOFr (%)Immediately prior to start of surgery

Train of four (TOF) is measured by giving 4 quick electrical pulses to the muscle and counting the number of muscle twitches. Baseline TOFr is the ratio between the fourth twitch of the train of four (TOF) sequence (T4) and the first (T1) prior to administration of the neuromuscular blocking agent and then multiplied by 100 to get a percentage. A lower TOFr equals stronger neuromuscular block and more muscle paralysis.

Secondary Outcome Measures
NameTimeMethod
Recovered Amplitude (mV)At the end of surgery (maximum 7 hours from baseline)

The amplitude of the muscle action potential after recovery from the neuromuscular blocking agent.

Rate of Muscle Recovery (Minutes)At the end of surgery (maximum 7 hours from baseline)

The amount of time it took to return to a TOFr \>90% following reversal of neuromuscular blocking agent.

Baseline Amplitude (mV)Immediately prior to start of surgery

The amplitude of the muscle action potential prior to administration of the neuromuscular blocking agent.

Trial Locations

Locations (1)

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath